Navigation Links
AMT Obtains License to Amgen's GDNF Gene to Develop Treatment for Parkinson's Disease with AMT's Proprietary Gene Therapy Platform
Date:9/17/2008

AMSTERDAM, The Netherlands, September 18 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it obtained a license from Amgen to use their GDNF gene for the development of a gene therapy treatment for Parkinson's disease. The combination of this gene with AMT's proprietary adeno-associated virus (AAV) gene therapy platform could potentially allow the development of an effective, long-term treatment for this progressive and crippling disease.

Parkinson's disease is the second most common neurodegenerative disease. It usually affects people over 65 with an estimated total of 4.5 million patients worldwide. Due to increasing life expectancy of the general population, the number of patients with Parkinson's disease is expected to double to around 9 million patients between now and the year 2030.

Patients with Parkinson's disease slowly lose control of their muscles, resulting in tremors, stiffness, slowness of movement, and lack of coordination and thus in a serious loss of quality of life. Parkinson's is caused by degeneration and death of nerve cells in a specific part of the brain. These cells produce dopamine, a substance necessary for communication between nerve cells involved in the coordination of movement. Current therapies are limited to treatment of symptoms. There are no therapies available that slow down or halt the progression of the disease.

A new way to deliver the GDNF gene

"This license from Amgen offers us a unique opportunity to combine our gene technology and know-how with the GDNF gene as a tool to create a potential breakthrough in the treatment for this common and severely debilitating disease," said Ronald Lorijn, CEO of AMT "We believe our gene therapy approach could be an effective way to deliver the gene to the regions of the brain affected by Parkinson's disease."

Protect and improve nerve cells with GDNF


'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. First Molecular Tem-PCR Test to Identify Multiple Forms of Staph and MRSA Obtains CLIA Certificate
2. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
3. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
4. Stem Cell Sciences Announces the Creation of the Worlds First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
5. Diakron Licenses Anticoagulant Drug Candidate from Merck & Co., Inc.
6. CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
7. Duke Licenses ALPHADAS(R), Logos Technologies EDC System to Accelerate its Early Phase Clinical Trials
8. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
9. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
10. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
11. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., DELFT,TheNetherlandsandJOHANNESBURG,Novembe...visionandPyxisDiscoveryannouncedtoday,thattheyhave...ompanies,services. , Pyxis,sworldclasscomputa...pledwithiThemba,sservicedivisiontoprovidemedicinal...hroughPyxis,internationalclientnetwork.iThembaPha...
(Date:11/24/2009)..., IRVINE,Calif.,Nov.24/PRNewswire-FirstCall/-...yinvasivetreatmentsforaorticdisorders,announcedtod...eedingsin,thepatentinfringementlawsuitbroughtagain...UnitedStatesDistrictCourtinIndianapolis,Indiana. ,...twhiletheUnitedStatesPatentandTrademarkOffice(USPT...
(Date:11/24/2009)..., POTOMAC,Md.,Nov.24/PRNewswire/--Inadditiont...kihasaddedPhiladelphiajurorstoherThanksgivinggrati...oice.Iamsothankfultothem,"shesaidofMonday,sverdict...ticals. ,, Wisneskiisamong12,000womennationwide...hehormonetherapydrugsPremarinandPrempro.Wisneskian...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Maryland Woman Thankful for Wyeth Verdicts 2At last 21 A Remarkable Breakthrough for Parkinson 26apos 3Bs Disease Freezing 3A The GaitAid Virtual Walker 55077 1At last 21 A Remarkable Breakthrough for Parkinson 26apos 3Bs Disease Freezing 3A The GaitAid Virtual Walker 55077 2At last 21 A Remarkable Breakthrough for Parkinson 26apos 3Bs Disease Freezing 3A The GaitAid Virtual Walker 55077 3Dominique Wilkins Scores Big for Diabetes in Fayette County 55073 1Dominique Wilkins Scores Big for Diabetes in Fayette County 55073 2Dominique Wilkins Scores Big for Diabetes in Fayette County 55073 3Going Back to School With Asthma Takes Extra Work 55070 1Going Back to School With Asthma Takes Extra Work 55070 2
...REDERICK, Md., April 8, 2008 ImQuest scientists R... M.S. presented the results of,studies performed w...c. at,the recent Microbicides 2008, an internation...d by microbicide scientists, developers, and care,...ited to speak by the,Conference organizers, presen...
...ong-term arrangement between two leading non-profi...rgets for the fatal,neurodegenerative disease that...l 8, 2008 The ALS,Therapy Development Institute (...reement with the Allen Institute for Brain Science... services using diseased tissues from a,preclinica...
Other Medicine Technology:ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India 2ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science 2ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science 3
(Date:11/25/2009)...wswire/-SentinelleMedicalInc.,aleadingmanufacturer...unchesasuiteofnewleadingedgeclinicalapplicationson...ar,sRadiologicalSocietyofNorthAmerica(RSNA)annualm....Theapplicationsleveragetheuniquehighqualityimages...ndsupportmultipleimagingmodalitiesformulti-paramet...
(Date:11/25/2009)...rsements,Business,andPressJoinEfforttoEducate ,...ceagain,theNationalBipolarFoundationandtheMedicAle...e,tilStable"program,whichisnowbeingwidelyaccepteda...day,theNationalBipolarFoundationreceivedaproclamat...heLt.GovernorofLouisianaMitchLandrieu.TheNationalB...
(Date:11/25/2009)...was too short to draw definite conclusions, expert...y News) -- In diabetic patients with blocked coron... outcomes at one year whether patients undergo byp...researchers report. , Bypass surgery has been t...oronary artery disease. However, less invasive app...
(Date:11/25/2009)...sees few signs of trouble with the H1N1 vaccine, ...-- The ongoing H1N1 swine flu pandemic may be driv...ounger patients, a U.S. health official said Wedne...neumococcal infections around the country," Dr. An...mmunization and Respiratory Diseases at the U.S. C...
(Date:11/25/2009)...rectal cancer also can reverse a rare stomach diso...or the disease, researchers at Vanderbilt Universi...isease causes thickening of the stomach lining, se...as anemia and swelling in the feet and ankles due ...r gastric cancer. Previously, the only effective t...
Breaking Medicine News(10 mins):Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
... It is well-known that back pain belongs to the mo...ons and, it is also well-known that it is the caus...es and the economy. In the period of just one year... in Greifswald, Christina Wenig and Bernd Schweike...
... breast, ovarian cancers, HERNDON, Va., June 17 ...e-chartered non-profit, announced today,that its G... of Funds, made,a $100,000 early-stage investment ..."We are proud to receive an investment from an org...
...um for Showing Support and, Generating Awareness ... Reign as a Leading Cause of Dea...cognized,leader in user generated commerce, is ple...isease that too often takes,lives to one that peop...
...uses has shed new light on how our brains store an...artment of Neurobiology at the Alexander Silberman...ty of Jerusalem., Why octopuses?, Octopuses and ot...y can be trained for various learning and memory t...
...tein recommendations were established with the goa...icates that many adults may benefit from eating mo...e presented in a supplement in the May issue of th...ding scientists in protein research. , The summi...
... mortality almost in half, study finds , ...ptions for repair of ruptured abdominal aneurysms ...ents, says a study by researchers at the Medical U... and abdomen -- enlarges and bursts. In most cases...
Other Medicine News:Health News:Socio-demographic factors influence costs of back pain 2Health News:CIT GAP Funds Invests in OTraces, Inc. 2Health News:CafePress Supports Stand Up To Cancer With Online Store to Help Raise Awareness and Funds for Research 2Health News:Hebrew University research on octopuses sheds light on memory 2Health News:Hebrew University research on octopuses sheds light on memory 3Health News:Is it time to revisit the current protein recommendations? 2Health News:Is it time to revisit the current protein recommendations? 3Health News:2nd Option Improves Abdominal Aorta Repair Outcomes 2
Clear, Universal, Adult
Disposable Switch-a-Tip, with loop tip (used with Cauterette I or III)
Cauterette III, Fixed high temperature handle (requires disposable tips)
Vari-I-Temp, 813 - 1148C (1495-2098F), 1/2" shaft with fine tip
Medicine Products: